Decentralized Clinical Trial Technology Using Tablet

What are Sponsors and CROs Demanding from Decentralized Clinical Trial Technologies

Decentralized clinical trial technologies (DCTs) may include at least one of the following patient engagement components: wearable sensors to collect data from a patient, telemedicine, ePRO (electronic patient-reported outcomes), eConsent, and delivery of study devices, medication, as well as other supplies directly to patients through an RTSM (randomization and trial supply management system). It doesn’t…

Clinical Electronic Data Capture High Technology

Modernizing Clinical Electronic Data Capture and Management

With time, clinical trials are becoming more intricate and convergence of forces—including precise value differentiation, increasing protocol complexity, and more emphasis on patient experience—is accelerating this intricacy. Clinical electronic data capture systems and processes have evolved to include adaptive designs, DCTs (decentralized clinical trials), increased data volume and precision, and an ever-expanding array of data…

Centralized Research Team With Centralized Monitoring of Clinical Trials

Importance of Centralized Monitoring in Clinical Trials for Data Integrity

Since technological advancements have allowed for more data-driven clinical research, centralized monitoring in clinical trials has become an important approach in off-site and on-site monitoring plans. Here, we discuss the importance of centralized Monitoring in clinical trials for data integrity in clinical trials. 1. Centralized Monitoring in Clinical Trials Effect on Cost Efficiency Clinical process…

Clinical Trial Diversity in Covid-19 Example

Important Lessons Learned from the COVID-19 Crisis for Clinical Trial Diversity

Sponsors and sites struggled with clinical trial diversity way before the Coronavirus pandemic began. Approximately 20% of new drugs have different effects depending on an individual’s race. This makes it important for newer treatments to be tested on a diverse patient population. Yet disabled, elderly, Hispanic, and African American patients are typically underrepresented in clinical…